Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 34, Issue 2, Pages 127-140
Publisher
Elsevier BV
Online
2022-11-10
DOI
10.1016/j.annonc.2022.10.506
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adjuvant S-1 versus observation in curatively resected biliary tract cancer: A phase III trial (JCOG1202: ASCOT).
- (2022) Masafumi Ikeda et al. JOURNAL OF CLINICAL ONCOLOGY
- Updated results of the FOENIX-CCA2 trial: Efficacy and safety of futibatinib in intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 fusions/rearrangements.
- (2022) Lipika Goyal et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab deruxtecan (T-DXd; DS-8201) in patients (pts) with HER2-expressing unresectable or recurrent biliary tract cancer (BTC): An investigator-initiated multicenter phase 2 study (HERB trial).
- (2022) Akihiro Ohba et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting HER2 mutation–positive advanced biliary tract cancers with neratinib: Final results from the phase 2 SUMMIT basket trial.
- (2022) James J. Harding et al. JOURNAL OF CLINICAL ONCOLOGY
- Zanidatamab (ZW25) in HER2-positive biliary tract cancers (BTCs): Results from a phase I study.
- (2021) Funda Meric-Bernstam et al. JOURNAL OF CLINICAL ONCOLOGY
- Liver transplantation for perihilar cholangiocarcinoma: patient selection and outcomes
- (2021) Alexandra W. Acher et al. Expert Review of Gastroenterology & Hepatology
- Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial
- (2021) Angela Lamarca et al. LANCET ONCOLOGY
- Analysis of metastasis and survival between extrahepatic and intrahepatic cholangiocarcinoma
- (2021) Peng Liao et al. MEDICINE
- Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysis
- (2021) Julien Edeline et al. CANCER TREATMENT REVIEWS
- Long-term efficacy and safety of larotrectinib in an integrated dataset of patients with TRK fusion cancer.
- (2021) David S. Hong et al. JOURNAL OF CLINICAL ONCOLOGY
- Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study
- (2021) Milind Javle et al. LANCET ONCOLOGY
- Futibatinib, an irreversible FGFR1-4 inhibitor, in patients with advanced solid tumors harboring FGF/FGFR aberrations: a phase I dose-expansion study
- (2021) Funda Meric-Bernstam et al. Cancer Discovery
- Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation
- (2021) Andrew X. Zhu et al. JAMA Oncology
- Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II Study
- (2021) Jean marc Phelip et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study
- (2021) Juan W Valle et al. LANCET ONCOLOGY
- Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study
- (2021) Changhoon Yoo et al. LANCET ONCOLOGY
- Survival benefit of lymphadenectomy for gallbladder cancer based on the therapeutic index: An analysis of the US extrahepatic biliary malignancy consortium
- (2020) Kota Sahara et al. JOURNAL OF SURGICAL ONCOLOGY
- Downstaging with Radioembolization or Chemotherapy for Initially Unresectable Intrahepatic Cholangiocarcinoma
- (2020) Diane Riby et al. ANNALS OF SURGICAL ONCOLOGY
- Rehabilitation strategies following oesophagogastric and Hepatopancreaticobiliary cancer (ReStOre II): a protocol for a randomized controlled trial
- (2020) Linda O’Neill et al. BMC CANCER
- Exogenous hormone use, reproductive factors and risk of intrahepatic cholangiocarcinoma among women: results from cohort studies in the Liver Cancer Pooling Project and the UK Biobank
- (2020) Jessica L. Petrick et al. BRITISH JOURNAL OF CANCER
- Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
- (2020) Ghassan K Abou-Alfa et al. LANCET ONCOLOGY
- Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
- (2020) Ghassan K Abou-Alfa et al. LANCET ONCOLOGY
- Cholangiocarcinoma 2020: the next horizon in mechanisms and management
- (2020) Jesus M. Banales et al. Nature Reviews Gastroenterology & Hepatology
- Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma
- (2020) Diamantis I. Tsilimigras et al. JAMA Surgery
- Cholangiocarcinoma miscoding in hepatobiliary centres
- (2020) Shaun Selvadurai et al. EJSO
- Liver metastases of intrahepatic cholangiocarcinoma: implications for a potential new staging system.
- (2020) Angela Lamarca et al. HEPATOLOGY
- Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial
- (2020) Vivek Subbiah et al. LANCET ONCOLOGY
- Efficacy and Safety of Digital Single-Operator Cholangioscopy in the Diagnosis of Indeterminate Biliary Strictures by Targeted Biopsies: A Systematic Review and Meta-Analysis
- (2020) Li-Jia Wen et al. Diagnostics
- Endoscopic radiofrequency ablation plus plastic stent placement versus stent placement alone for unresectable extrahepatic biliary cancer: a multicenter randomized controlled trial
- (2020) Dao-Jian Gao et al. GASTROINTESTINAL ENDOSCOPY
- PET/MRI of the hepatobiliary system: Review of techniques and applications
- (2020) Preethi Guniganti et al. CLINICAL IMAGING
- Cholangiocarcinoma: Epidemiology and risk factors
- (2019) Shahid A. Khan et al. LIVER INTERNATIONAL
- Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
- (2019) John N Primrose et al. LANCET ONCOLOGY
- Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma
- (2019) Paola Bertuccio et al. JOURNAL OF HEPATOLOGY
- 18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) for patients with biliary tract cancer: systematic review and meta-analysis
- (2019) Angela Lamarca et al. JOURNAL OF HEPATOLOGY
- Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study
- (2019) Julien Edeline et al. JOURNAL OF CLINICAL ONCOLOGY
- Serum CA 19.9 Levels in Patients With Benign and Malignant Disease: Correlation With the Serum Protein Electrophoretic Pattern
- (2019) SIMON GUNDÍN-MENÉNDEZ et al. ANTICANCER RESEARCH
- Stereotactic body radiation therapy in cholangiocarcinoma: a systematic review
- (2019) Rezarta Frakulli et al. BRITISH JOURNAL OF RADIOLOGY
- Comprehensive genomic profiling in FIGHT-202 reveals the landscape of actionable alterations in advanced cholangiocarcinoma.
- (2019) Ian M. Silverman et al. JOURNAL OF CLINICAL ONCOLOGY
- Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers
- (2019) Rachna T. Shroff et al. JAMA Oncology
- The jigsaw of dual hepatocellular–intrahepatic cholangiocarcinoma tumours
- (2019) Patricia Munoz-Garrido et al. Nature Reviews Gastroenterology & Hepatology
- Risk Factors for Intrahepatic and Extrahepatic Cholangiocarcinoma: a systematic review and meta-analysis
- (2019) Oliver Clements et al. JOURNAL OF HEPATOLOGY
- Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial
- (2019) C Morizane et al. ANNALS OF ONCOLOGY
- Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
- (2019) Aurelien Marabelle et al. JOURNAL OF CLINICAL ONCOLOGY
- Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma
- (2019) Julien Edeline et al. JAMA Oncology
- Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma
- (2019) Andrea Cercek et al. JAMA Oncology
- Modified gemcitabine and oxaliplatin or gemcitabine + cisplatin in unresectable gallbladder cancer: Results of a phase III randomised controlled trial
- (2019) Atul Sharma et al. EUROPEAN JOURNAL OF CANCER
- Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials
- (2019) Robert C Doebele et al. LANCET ONCOLOGY
- IgG4-Associated Cholangitis in Patients Resected for Presumed Perihilar Cholangiocarcinoma: a 30-Year Tertiary Care Experience
- (2018) Eva Roos et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer
- (2018) T. Ebata et al. BRITISH JOURNAL OF SURGERY
- cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation
- (2018) Elizabeth Brunt et al. HEPATOLOGY
- Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma
- (2018) Milind Javle et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study
- (2018) John D. Hainsworth et al. JOURNAL OF CLINICAL ONCOLOGY
- Body Mass Index, Diabetes and Intrahepatic Cholangiocarcinoma Risk: The Liver Cancer Pooling Project and Meta-analysis
- (2018) Jessica L. Petrick et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
- (2018) J Mateo et al. ANNALS OF ONCOLOGY
- FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
- (2018) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline
- (2017) Lars Aabakken et al. JOURNAL OF HEPATOLOGY
- Improving patient selection for selective internal radiation therapy of intra-hepatic cholangiocarcinoma: A meta-regression study
- (2017) Alessandro Cucchetti et al. LIVER INTERNATIONAL
- Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
- (2017) Apinya Jusakul et al. Cancer Discovery
- Aspirin use and the risk of cholangiocarcinoma
- (2016) Jonggi Choi et al. HEPATOLOGY
- Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise
- (2016) Supriya K. Saha et al. ONCOLOGIST
- The association between BMI and gallbladder cancer risk: a meta-analysis
- (2016) Zhan-Ming Li et al. Oncotarget
- Salmonella entericaserovar Typhi and gallbladder cancer: a case-control study and meta-analysis
- (2016) Jill Koshiol et al. Cancer Medicine
- Awareness of Tract Seeding With Endoscopic Ultrasound Tissue Acquisition in Perihilar Cholangiocarcinoma
- (2015) Nataliya Razumilava et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Surgical Management of Intrahepatic Cholangiocarcinoma: Defining an Optimal Prognostic Lymph Node Stratification Schema
- (2015) Yuhree Kim et al. ANNALS OF SURGICAL ONCOLOGY
- The Impact of Surgical Margin Status on Long-Term Outcome After Resection for Intrahepatic Cholangiocarcinoma
- (2015) Gaya Spolverato et al. ANNALS OF SURGICAL ONCOLOGY
- Pathologic classification of cholangiocarcinoma: New concepts
- (2015) Yasuni Nakanuma et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Cohort profile: cholangiocarcinoma screening and care program (CASCAP)
- (2015) Narong Khuntikeo et al. BMC CANCER
- Cisplatin and gemcitabine in patients with advanced biliary tract cancer (ABC) and persistent jaundice despite optimal stenting: Effective intervention in patients with luminal disease
- (2015) Angela Lamarca et al. EUROPEAN JOURNAL OF CANCER
- Single-operator cholangioscopy and targeted biopsies in the diagnosis of indeterminate biliary strictures: a systematic review
- (2015) Udayakumar Navaneethan et al. GASTROINTESTINAL ENDOSCOPY
- SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma
- (2015) Edgar Ben-Josef et al. JOURNAL OF CLINICAL ONCOLOGY
- The Utility of Immunohistochemistry in Subtyping Adenocarcinoma of the Ampulla of Vater
- (2014) Daphne C. Ang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Guidelines for pancreaticobiliary cytology from the Papanicolaou Society of Cytopathology: A review
- (2014) Martha B. Pitman et al. CANCER CYTOPATHOLOGY
- EUS-FNA is superior to ERCP-based tissue sampling in suspected malignant biliary obstruction: results of a prospective, single-blind, comparative study
- (2014) Frank Weilert et al. GASTROINTESTINAL ENDOSCOPY
- Outcomes in operative management of pancreatic cancer
- (2014) Lindsay A. Bliss et al. JOURNAL OF SURGICAL ONCOLOGY
- Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma
- (2014) Michael N. Mavros et al. JAMA Surgery
- Clinical applications of 18F-FDG PET in the management of hepatobiliary and pancreatic tumors
- (2012) Anna Maria De Gaetano et al. ABDOMINAL IMAGING
- Radiological staging in patients with hilar cholangiocarcinoma: a systematic review and meta-analysis
- (2012) A T Ruys et al. BRITISH JOURNAL OF RADIOLOGY
- Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis
- (2012) Anne M. Horgan et al. JOURNAL OF CLINICAL ONCOLOGY
- Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma
- (2012) William C. Palmer et al. JOURNAL OF HEPATOLOGY
- Rising trends in cholangiocarcinoma: Is the ICD classification system misleading us?
- (2011) Shahid A. Khan et al. JOURNAL OF HEPATOLOGY
- Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
- (2010) T Okusaka et al. BRITISH JOURNAL OF CANCER
- Gallbladder cancer: Incidence and survival in a high-risk area of Chile
- (2010) Enriqueta Bertran et al. INTERNATIONAL JOURNAL OF CANCER
- Best Supportive Care Compared With Chemotherapy for Unresectable Gall Bladder Cancer: A Randomized Controlled Study
- (2010) Atul Sharma et al. JOURNAL OF CLINICAL ONCOLOGY
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gallbladder disease in patients with primary sclerosing cholangitis
- (2008) Karouk Said et al. JOURNAL OF HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started